Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain

Journal of Magnetic Resonance Imaging

Volumn 42, Issue 1, 2015, Pages 23-41

  Liu, Chunlei ^a   Li, Wei ^b   Tong, Karen A ^c   Yeom, Kristen W ^d   Kuzminski, Samuel ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

hemorrhage; iron; MRI magnetic resonance imaging; MSA magnetic susceptibility anisotropy; multiple sclerosis; myelin; QSM quantitative susceptibility mapping; STI susceptibility tensor imaging; stroke; SWI susceptibility weighted imaging; TBI traumatic brain injury

Indexed keywords

IRON; MYELIN;

BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN LEVEL; BRAIN MAPPING; BRAIN TUMOR; CAVERNOUS HEMANGIOMA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTRAST ENHANCEMENT; DEOXYGENATION; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; MAGNETISM; MULTIPLE SCLEROSIS; MYELINATION; NEUROANATOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE SUSCEPTIBILITY MAPPING; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SUSCEPTIBILITY TENSOR IMAGING; SUSCEPTIBILITY WEIGHTED IMAGING; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; BRAIN DISEASE; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; GRAY MATTER; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; WHITE MATTER;

ANIMALS; BRAIN; BRAIN DISEASES; DIFFUSION MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WHITE MATTER;

EID: 84931830202     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24768     Document Type: Review

References (139)

1. Haacke EM, Xu Y, Cheng YC, Reichenbach JR,. Susceptibility weighted imaging (SWI). Magn Reson Med 2004; 52: 612-618.
2. de Crespigny AJ, Roberts TP, Kucharcyzk J, Moseley ME,. Improved sensitivity to magnetic susceptibility contrast. Magn Reson Med 1993; 30: 135-137.
3. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM,. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997; 204: 272-277.
4. de Rochefort L, Brown R, Prince MR, Wang Y,. Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn Reson Med 2008; 60: 1003-1009.
5. Shmueli K, de Zwart JA, van Gelderen P, Li TQ, Dodd SJ, Duyn JH,. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med 2009; 62: 1510-1522.
6. Young IR, Khenia S, Thomas DG, et al., Clinical magnetic susceptibility mapping of the brain. J Comput Assist Tomogr 1987; 11: 2-6.
7. Weisskoff RM, Kiihne S,. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood. Magn Reson Med 1992; 24: 375-383.
8. Li L,. Magnetic susceptibility quantification for arbitrarily shaped objects in inhomogeneous fields. Magn Reson Med 2001; 46: 907-916.
9. Li W, Wu B, Liu C,. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011; 55: 1645-1656.
10. Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E,. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012; 59: 2625-2635.
11. Wu B, Li W, Guidon A, Liu C,. Whole brain susceptibility mapping using compressed sensing. Magn Reson Med 2012; 67: 137-147.
12. Liu J, Liu T, de Rochefort L, et al., Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012; 59: 2560-2568.
13. Marques JP, Bowtell R,. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concept Magn Reson B 2005; 25B: 65-78.
14. Salomir R DSB, Moonen CTW,. A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility. Concepts Magn Reson Part B 2003; 19B: 26-34.
15. Wharton S, Bowtell R,. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. Neuroimage 2010; 53: 515-525.
16. Schweser F, Deistung A, Lehr BW, Reichenbach JR,. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med Phys 2010; 37: 5165-5178.
17. Tang J, Liu S, Neelavalli J, Cheng YCN, Buch S, Haacke EM,. Improving susceptibility mapping using a threshold-based k-space/image domain iterative reconstruction approach. Magn Reson Med 2013; 69: 1396-1407.
18. Dibb R, Li W, Cofer W, Liu C,. Microstructural origins of gadolinium-enhanced susceptibility contrast and anisotropy. Magn Reson Med 2014 [Epub ahead of print].
19. Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ,. In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS One 2013; 8: e81093.
20. Argyridis I, Li W, Johnson GA, Liu C,. Quantitative magnetic susceptibility of the developing mouse brain reveals microstructural changes in the white matter. Neuroimage 2013 [Epub ahead of print].
21. Deistung A, Schweser F, Wiestler B, et al., Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PLoS One 2013; 8: e57924.
22. Langkammer C, Liu T, Khalil M, et al., Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013; 267: 551-559.
23. Li W, Avram AV, Wu B, Xiao X, Liu C,. Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed 2013 [Epub ahead of print].
24. Li W, Wu B, Batrachenko A, et al., Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan. Hum Brain Mapp 2013 [Epub ahead of print].
25. Lim IA, Faria AV, Li X, et al., Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures. Neuroimage 2013; 82C: 449-469.
26. Liu T, Wisnieff C, Lou M, Chen W, Spincemaille P, Wang Y,. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn Reson Med 2013; 69: 467-476.
27. Schweser F, Deistung A, Sommer K, Reichenbach JR,. Toward online reconstruction of quantitative susceptibility maps: superfast dipole inversion. Magn Reson Med 2013; 69: 1582-1594.
28. Sun H, Wilman AH,. Background field removal using spherical mean value filtering and Tikhonov regularization. Magn Reson Med 2013 [Epub ahead of print].
29. Wang S, Lou M, Liu T, Cui D, Chen X, Wang Y,. Hematoma volume measurement in gradient echo MRI using quantitative susceptibility mapping. Stroke 2013; 44: 2315-2317.
30. Xie L, Sparks MA, Li W, et al., Quantitative susceptibility mapping of kidney inflammation and fibrosis in type 1 angiotensin receptor-deficient mice. NMR Biomed 2013; 26: 1853-1863.
31. Zheng W, Nichol H, Liu S, Cheng YC, Haacke EM,. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage 2013; 78: 68-74.
32. Balla DZ, Sanchez-Panchuelo RM, Wharton SJ, et al., Functional quantitative susceptibility mapping (fQSM). Neuroimage 2014; 100: 112-124.
33. Bonekamp D, Barker PB, Leigh R, van Zijl PC, Li X,. Susceptibility-based analysis of dynamic gadolinium bolus perfusion MRI. Magn Reson Med 2014 [Epub ahead of print].
34. Chen W, Gauthier SA, Gupta A, et al., Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014; 271: 183-192.
35. Liu C,. Susceptibility tensor imaging. Magn Reson Med 2010; 63: 1471-1477.
36. Li X, Vikram DS, Lim IA, Jones CK, Farrell JA, van Zijl PC,. Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7 T. Neuroimage 2012; 62: 314-330.
37. Li W, Wu B, Avram AV, Liu C,. Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. Neuroimage 2012; 59: 2088-2097.
38. Liu C, Li W, Wu B, Jiang Y, Johnson GA,. 3D fiber tractography with susceptibility tensor imaging. Neuroimage 2012; 59: 1290-1298.
39. Wisnieff C, Liu T, Spincemaille P, Wang S, Zhou D, Wang Y,. Magnetic susceptibility anisotropy: cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations. Neuroimage 2013; 70: 363-376.
40. Xie L, Dibb R, Cofer GP, et al., Susceptibility tensor imaging of the kidney and its microstructural underpinnings. Magn Reson Med 2014 [Epub ahead of print].
41. Lee J, Shmueli K, Fukunaga M, et al., Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc Natl Acad Sci U S A 2010; 107: 5130-5135.
42. Wharton S, Bowtell R,. Fiber orientation-dependent white matter contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2012; 109: 18559-18564.
43. Li X, van Zijl PC,. Mean magnetic susceptibility regularized susceptibility tensor imaging (MMSR-STI) for estimating orientations of white matter fibers in human brain. Magn Reson Med 2014; 72: 610-619.
44. Sukstanskii AL, Yablonskiy DA,. On the role of neuronal magnetic susceptibility and structure symmetry on gradient echo MR signal formation. Magn Reson Med 2014; 71: 345-353.
45. Li W, Liu C,. Comparison of magnetic susceptibility tensor and diffusion tensor of the brain. J Neurosci Neuroeng 2013; 2: 431-440.
46. Liu C, Murphy NE, Li W,. Probing white-matter microstructure with higher-order diffusion tensors and susceptibility tensor MRI. Front Integr Neurosci 2013; 7: 11.
47. Arrighin GP, Maestro M, Moccia R,. Magnetic properties of polyatomic molecules. I. Magnetic susceptibility of H2o,Nh3, Ch4, H2o2. J Chem Phys 1968; 49: 882.
48. Schweser F, Deistung A, Lehr BW, Reichenbach JR,. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011; 54: 2789-2807.
49. Cullity BD, Graham CD,. Introduction to magnetic materials. Hoboken, NJ: IEEE/Wiley; 2009.
50. Levitt MH,. The signs of frequencies and phases in NMR. J Magn Reson 1997; 126: 164-182.
51. Abdul-Rahman HS, Gdeisat MA, Burton DR, Lalor MJ, Lilley F, Moore CJ,. Fast and robust three-dimensional best path phase unwrapping algorithm. Appl Opt 2007; 46: 6623-6635.
52. Jenkinson M,. Fast, automated, N-dimensional phase-unwrapping algorithm. Magn Reson Med 2003; 49: 193-197.
53. Liu T, Khalidov I, de Rochefort L, et al., A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed 2011; 24: 1129-1136.
54. Glover GH,. Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1991; 1: 521-530.
55. Conturo TE, Barker PB, Mathews VP, Monsein LH, Bryan RN,. MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts. Magn Reson Med 1992; 27: 375-390.
56. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR,. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005; 26: 736-742.
57. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M,. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A 2007; 104: 11796-11801.
58. Cho ZH, Ro YM, Lim TH,. NMR venography using the susceptibility effect produced by deoxyhemoglobin. Magn Reson Med 1992; 28: 25-38.
59. Yablonskiy DA, Haacke EM,. Theory of NMR signal behavior in magnetically inhomogeneous tissues-the static dephasing regime. Magn Reson Med 1994; 32: 749-763.
60. Liu C, Li W,. Imaging neural architecture of the brain based on its multipole magnetic response. Neuroimage 2013; 67: 193-202.
61. Hallgren B, Sourander P,. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958; 3: 41-51.
62. Langkammer C, Schweser F, Krebs N, et al., Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012; 62: 1593-1599.
63. Kawamura Y, Sakurai I, Ikegami A, Iwayanagi S,. Magneto-orientation of phospholipids. Mol Cryst Liq Cryst 1981; 67: 733-743.
64. Lonsdale K,. Diamagnetic anisotropy of organic molecules. Proc R Soc Lond Ser A 1939; 171: 0541-0568.
65. Liu C, Li W, Johnson GA, Wu B,. High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage 2011; 56: 930-938.
66. Lee J, Shmueli K, Kang BT, et al., The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. Neuroimage 2012; 59: 3967-3975.
67. Zhong K, Ernst T, Buchthal S, Speck O, Anderson L, Chang L,. Phase contrast imaging in neonates. Neuroimage 2011; 55: 1068-1072.
68. Lodygensky GA, Marques JP, Maddage R, et al., In vivo assessment of myelination by phase imaging at high magnetic field. Neuroimage 2012; 59: 1979-1987.
69. van Gelderen P, de Zwart JA, Lee J, Sati P, Reich DS, Duyn JH,. Nonexponential T(2) decay in white matter. Magn Reson Med 2012; 67: 110-117.
70. Chen WC, Foxley S, Miller KL,. Detecting microstructural properties of white matter based on compartmentalization of magnetic susceptibility. Neuroimage 2013; 70: 1-9.
71. He X, Yablonskiy DA,. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2009; 106: 13558-13563.
72. Ogawa S, Lee TM, Kay AR, Tank DW,. Brain magnetic-resonance-imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990; 87: 9868-9872.
73. Lee J, Hirano Y, Fukunaga M, Silva AC, Duyn JH,. On the contribution of deoxy-hemoglobin to MRI gray-white matter phase contrast at high field. Neuroimage 2010; 49: 193-198.
74. Zhong K, Leupold J, von Elverfeldt D, Speck O,. The molecular basis for gray and white matter contrast in phase imaging. Neuroimage 2008; 40: 1561-1566.
75. Essig M, Reichenbach JR, Schad LR, Schoenberg SO, Debus J, Kaiser WA,. High-resolution MR venography of cerebral arteriovenous malformations. Magn Reson Imaging 1999; 17: 1417-1425.
76. Hermier M, Nighoghossian N, Derex L, et al., MRI of acute post-ischemic cerebral hemorrhage in stroke patients: diagnosis with T2-weighted gradient-echo sequences. Neuroradiology 2001; 43: 809-815.
77. Tong KA, Ashwal S, Holshouser BA, et al., Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003; 227: 332-339.
78. Tong KA, Ashwal S, Holshouser BA, et al., Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 2004; 56: 36-50.
79. Wycliffe ND, Choe J, Holshouser B, Oyoyo UE, Haacke EM, Kido DK,. Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging 2004; 20: 372-377.
80. Choi JH, Mohr JP,. Brain arteriovenous malformations in adults. Lancet Neurol 2005; 4: 299-308.
81. Idbaih A, Boukobza M, Crassard I, Porcher R, Bousser MG, Chabriat H,. MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images. Stroke 2006; 37: 991-995.
82. Jeon SB, Kang DW, Cho AH, et al., Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage. J Neurol 2007; 254: 508-512.
83. Chastain CA, Oyoyo UE, Zipperman M, et al., Predicting outcomes of traumatic brain injury by imaging modality and injury distribution. J Neurotrauma 2009; 26: 1183-1196.
84. de Champfleur NM, Langlois C, Ankenbrandt WJ, et al., Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery 2011; 68: 641-647; discussion 647-648.
85. Jagadeesan BD, Delgado Almandoz JE, Moran CJ, Benzinger TL,. Accuracy of susceptibility-weighted imaging for the detection of arteriovenous shunting in vascular malformations of the brain. Stroke 2011; 42: 87-92.
86. Viswanathan A, Greenberg SM,. Cerebral amyloid angiopathy in the elderly. Ann Neurol 2011; 70: 871-880.
87. Charidimou A, Werring DJ,. Cerebral microbleeds and cognition in cerebrovascular disease: an update. J Neurol Sci 2012; 322: 50-55.
88. Kinno R, Yamamoto M, Yamazaki T, Owan Y, Fukui T, Kinugasa E,. Cerebral microhemorrhage in Marchiafava-Bignami disease detected by susceptibility-weighted imaging. Neurol Sci 2013; 34: 545-548.
89. Zuccoli G, Panigrahy A, Haldipur A, et al., Susceptibility weighted imaging depicts retinal hemorrhages in abusive head trauma. Neuroradiology 2013; 55: 889-893.
90. Pauling L, Coryell CD,. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci U S A 1936; 22: 210-216.
91. Coryell CD, Stitt F, Pauling L,. The magnetic properties and structure of ferrihemoglobin (methemoglobin) and some of its compounds. J Am Chem Soc 1937; 59: 633-642.
92. Taylor DS, Coryell CD,. The magnetic susceptibility of the iron in ferrohenioglobin. J Am Chem Soc 1938; 60: 1177-1181.
93. Bradley WG Jr, Schmidt PG,. Effect of methemoglobin formation on the MR appearance of subarachnoid hemorrhage. Radiology 1985; 156: 99-103.
94. Michaelis L, Coryell CD, Granick S,. Ferritin III. The magnetic properties of ferritin and some other colloidal ferric compounds. J Biol Chem 1943; 148: 463-480.
95. Tsui YK, Tsai FY, Hasso AN, Greensite F, Nguyen BV,. Susceptibility-weighted imaging for differential diagnosis of cerebral vascular pathology: a pictorial review. J Neurol Sci 2009; 287: 7-16.
96. Lee BC, Vo KD, Kido DK, et al., MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol 1999; 20: 1239-1242.
97. Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM,. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008; 29: 9-17.
98. de Souza JM, Domingues RC, Cruz LCH, Domingues FS, Iasbeck T, Gasparetto EL,. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with T2-weighted fast spin-echo and gradient-echo sequences. Am J Neuroradiol 2008; 29: 154-158.
99. Rosand J, Muzikansky A, Kumar A, et al., Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 2005; 58: 459-462.
100. Baik SK, Choi W, Oh SJ, et al., Change in cortical vessel signs on susceptibility-weighted images after full recanalization in hyperacute ischemic stroke. Cerebrovasc Dis 2012; 34: 206-212.
101. Ashwal S, Holshouser BA, Tong KA,. Use of advanced neuroimaging techniques in the evaluation of pediatric traumatic brain injury. Dev Neurosci 2006; 28: 309-326.
102. Beauchamp MH, Beare R, Ditchfield M, et al., Susceptibility weighted imaging and its relationship to outcome after pediatric traumatic brain injury. Cortex 2013; 49: 591-598.
103. Sigmund GA, Tong KA, Nickerson JP, Wall CJ, Oyoyo U, Ashwal S,. Multimodality comparison of neuroimaging in pediatric traumatic brain injury. Pediatr Neurol 2007; 36: 217-226.
104. Wu Z, Li S, Lei J, An D, Haacke EM,. Evaluation of traumatic subarachnoid hemorrhage using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2010; 31: 1302-1310.
105. Dietrich WD, Alonso O, Halley M,. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma 1994; 11: 289-301.
106. Paterakis K, Karantanas AH, Komnos A, Volikas Z,. Outcome of patients with diffuse axonal injury: the significance and prognostic value of MRI in the acute phase. J Trauma 2000; 49: 1071-1075.
107. Linder MC, Hazegh-Azam M,. Copper biochemistry and molecular biology. Am J Clin Nutr 1996; 63: 797S-811S.
108. Ehrenberg A, Mosbach R, Malmstrom BG, Broman L,. Magnetic susceptibility study of copper valence in ceruloplasmin and laccase. J Mol Biol 1962; 5: 450.
109. Nalbandyan RM,. Copper in brain. Neurochem Res 1983; 8: 1211-1232.
110. Demer LL, Tintut Y,. Vascular calcification-pathobiology of a multifaceted disease. Circulation 2008; 117: 2938-2948.
111. Hopkins JA, Wehrli FW,. Magnetic susceptibility measurement of insoluble solids by NMR: magnetic susceptibility of bone. Magn Reson Med 1997; 37: 494-500.
112. Schneider SA, Bhatia KP,. Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). J Neural Transm 2013; 120: 695-703.
113. Drayer BP, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S,. Parkinson plus syndrome-diagnosis using high-field MR imaging of brain iron. Radiology 1986; 159: 493-498.
114. Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB,. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Trans Parkinson's Dis Dement Sect 1990; 2: 327-340.
115. Haacke EM, Makki M, Ge Y, et al., Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009; 29: 537-544.
116. Lotfipour AK, Wharton S, Schwarz ST, et al., High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging 2012; 35: 48-55.
117. Cosottini M, Frosini D, Pesaresi I, et al., MR Imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology 2014; 271: 831-838.
118. Lee JH, Yang TI, Cho M, Yoon KT, Baik SK, Han YH,. Widespread cerebral cortical mineralization in Wilson's disease detected by susceptibility-weighted imaging. J Neurol Sci 2012; 313: 54-56.
119. Bai X, Wang G, Wu L, et al., Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson's disease. Pediatr Res 2014; 75: 436-442.
120. Fritzsch D, Reiss-Zimmermann M, Trampel R, Turner R, Hoffmann KT, Schafer A,. Seven-Tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation. Invest Radiol 2014; 49: 299-306.
121. Tan IL, van Schijndel RA, Pouwels PJ, et al., MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 1039-1042.
122. Tallantyre EC, Dixon JE, Donaldson I, et al., Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology 2011; 76: 534-539.
123. Yao B, Bagnato F, Matsuura E, et al., Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 2012; 262: 206-215.
124. Zivadinov R, Weinstock-Guttman B, Pirko I,. Iron deposition and inflammation in multiple sclerosis. Which one comes first? BMC Neurosci 2011; 12: 60.
125. Qiu D, Chan GCF, Chu J, et al., MR quantitative susceptibility imaging for the evaluation of iron loading in the brains of patients with beta-thalassemia major. Am J Neuroradiol 2014; 35: 1085-1090.
126. Fan AP, Bilgic B, Gagnon L, et al., Quantitative oxygenation venography from MRI phase. Magn Reson Med 2013 [Epub ahead of print].
127. Xu B, Liu T, Spincemaille P, Prince M, Wang Y,. Flow compensated quantitative susceptibility mapping for venous oxygenation imaging. Magn Reson Med 2014; 72: 438-445.
128. Chen ZK, Liu JY, Calhoun VD,. Susceptibility-based functional brain mapping by 3D deconvolution of an MR-phase activation map. J Neurosci Meth 2013; 216: 33-42.
129. Bianciardi M, van Gelderen P, Duyn JH,. Investigation of BOLD fMRI resonance frequency shifts and quantitative susceptibility changes at 7 T. Hum Brain Mapp 2014; 35: 2191-2205.
130. Cao W, Li W, Han H, et al., Prenatal alcohol exposure reduces magnetic susceptibility contrast and anisotropy in the white matter of mouse brains. Neuroimage 2014 [Epub ahead of print].
131. Wu B, Li W, Avram AV, Gho SM, Liu C,. Fast and tissue-optimized mapping of magnetic susceptibility and T2∗ with multi-echo and multi-shot spirals. Neuroimage 2012; 59: 297-305.
132. Sun H, Wilman AH,. Quantitative susceptibility mapping using single-shot echo-planar imaging. Magn Reson Med 2014 [Epub ahead of print].
133. Du YPP, Jin ZY, Hu YZ, Tanabe J,. Multi-echo acquisition of MR angiography and venography of the brain at 3 Tesla. J Magn Reson Imaging 2009; 30: 449-454.
134. Denk C, Rauscher A,. Susceptibility weighted imaging with multiple echoes. J Magn Reson Imaging 2010; 31: 185-191.
135. Deistung A, Dittrich E, Sedlacik J, Rauscher A, Reichenbach JR,. ToF-SWI: simultaneous time of flight and fully flow compensated susceptibility weighted imaging. J Magn Reson Imaging 2009; 29: 1478-1484.
136. Meguro R, Asano Y, Odagiri S, Li C, Shoumura K,. Cellular and subcellular localizations of nonheme ferric and ferrous iron in the rat brain: a light and electron microscopic study by the perfusion-Perls and -Turnbull methods. Arch Histol Cytol 2008; 71: 205-222.
137. Skowronska M, Litwin T, Dziezyc K, Wierzchowska A, Czlonkowska A,. Does brain degeneration in Wilson disease involve not only copper but also iron accumulation? Neurol Neurochir Polska 2013; 47: 542-546.
138. Alvarez GA, Shemesh N, Frydman L,. Diffusion-assisted selective dynamical recoupling: a new approach to measure background gradients in magnetic resonance. J Chem Phys 2014; 140 (8).
139. Han SH, Song YK, Cho FH, et al., Magnetic field anisotropy based MR tractography. J Magn Reson 2011; 212: 386-393.